lobbying_activities: 995404

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
995404	01102a71-dcb7-4c0a-a036-d3fa314a7316	Q3	THE NORMANDY GROUP, LLC	306636	GENENTECH	2010	third_quarter	CPT	Monitor legislation regarding brand name and generic pharmaceutical agreements, patent fees, and post-grant review reforms.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2010-10-15T16:34:01.200000-04:00